000518.SZ
四环生物
SZSE · Healthcare · C 制造业 · CN
CNY 3.70
−2.63%Margins
Gross margin
30.3%
EBITDA margin
-7.3%
EBIT margin
-10.1%
Net margin
-8.5%
FCF margin
12.8%
-10.0%
Return on equity
-6.8%
Return on assets
-10.7%
Return on invested capital
0.78x
Asset turnover
CNY 52.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026